Fund detail
Duquesne Family Office (Druckenmiller)
hedge-fund, famous-pm, druckenmiller, macro, active
Quarters
52
2026-03-31
$3.38B
Positions
68
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Newamsterdam Pharma Company | $98.3M | 2.91% | 3,070,146 | +0 | +0.00% | 2.40% | 2024-09-30 | $32 | ~$26 | +24.33% | |
| 2 | State Str Spdr S&P 500 Etf T SPY | $58.5M | 1.73% | 90,000 | +0 | +0.00% | 1.37% | 2013-12-31 | $650 | ~$294 | +121.18% | |
| 3 | Protagonist Therapeutics Inc PTGX | $16.8M | 0.50% | 159,700 | +0 | +0.00% | 0.31% | 2025-09-30 | $105 | ~$66 | +58.66% | |
| 4 | Echostar Corp SATS | $7.1M | 0.21% | 60,765 | +0 | +0.00% | 0.15% | 2025-09-30 | $117 | ~$76 | +53.32% | |
| 5 | Almonty Inds Inc ALM | $6.8M | 0.20% | 469,880 | +0 | +0.00% | 0.09% | 2025-12-31 | $14 | ~$9 | +64.35% | |
| 6 | Wave Life Sciences Ltd | $1.3M | 0.04% | 173,000 | +0 | +0.00% | 0.07% | 2025-12-31 | $7 | ~$17 | -57.36% |